COVID vaccine from Germany’s CureVac just 48% effective
Germany’s CureVac said Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, […]
» Read moreA new Finnish study shows that 180 health care workers who had received two doses of the Pfizer and Biontech […] Alongside logistical and supply issues, vaccine hesitancy has been a notable hurdle in Australia’s troubled vaccine rollout. The news the […] As cases tumble and states reopen, the potential final stage in the U.S. campaign to vanquish COVID-19 is turning into […] BRUSSELS (Reuters) – The European Union plans to boost its early warning system and have a permanent capacity to produce […] Nearly 900 people received expired COVID-19 vaccine doses at a vaccination site in Times Square this month, health officials said […] Boarding pass, suitcase, passport and … digital vaccination certificate? Keen to avoid losing another summer of holiday revenue to the […] Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses […] Researchers from the University of Oxford, funded by the National Institute for Health (NIHR) Research Oxford Biomedical Research Center (BRC) […] Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard […]
COVID-19-mRNA vaccine induces good immune response against variants
Media reports about vaccine hesitancy could contribute to the problem
Vaccine effort turns into slog as infectious variant spreads
EU Wants Faster Vaccine Production in ‘Age of Pandemics’
899 people got expired vaccine doses at Times Square site
EXPLAINER: How vaccine passports for global travel will work
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages
COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant
Scientists unveil new Ebola virus vaccine design
